Publicacións nas que colabora con Rafael Franco Fernandez (21)

2024

  1. Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons

    npj Parkinson's Disease, Vol. 10, Núm. 1

  2. Neuroprotective compounds alter the expression of genes coding for proteins related to mitochondrial function in activated microglia

    Mitochondrion, Vol. 78

2023

  1. Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease

    Neurobiology of Disease, Vol. 188

  2. The cannabinoid CB1 receptor interacts with the angiotensin AT2 receptor. Overexpression of AT2-CB1 receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned rats

    Experimental Neurology, Vol. 362

2021

  1. An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria

    Redox Biology, Vol. 46

  2. Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19

    Clinical Science, Vol. 135, Núm. 3, pp. 465-481

  3. Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia

    Neurotherapeutics, Vol. 18, Núm. 2, pp. 998-1016

2020

  1. Angiotensin AT1and AT2receptor heteromer expression in the hemilesioned rat model of Parkinson's disease that increases with levodopa-induced dyskinesia

    Journal of Neuroinflammation, Vol. 17, Núm. 1

  2. Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra

    Brain, Behavior, and Immunity, Vol. 87, pp. 256-271

  3. Functional complexes of angiotensin-converting enzyme 2 and renin-angiotensin system receptors: Expression in adult but not fetal lung tissue

    International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-21

  4. SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production

    Journal of Immunology, Vol. 205, Núm. 5, pp. 1198-1206

2018

  1. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia

    Brain, Behavior, and Immunity, Vol. 67, pp. 139-151

  2. Usefulness of identifying g-protein-coupled receptor dimers for diagnosis and therapy of neurodegenerative diseases and of gliomas

    Histology and Histopathology, Vol. 33, Núm. 9, pp. 909-917

2017

  1. Neurochemical evidence supporting dopamine D1–D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation

    Brain Structure and Function, Vol. 222, Núm. 4, pp. 1767-1784

2016

  1. Hints on the Lateralization of Dopamine Binding to D 1 Receptors in Rat Striatum

    Molecular Neurobiology, Vol. 53, Núm. 8, pp. 5436-5445

  2. Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration

    Cell Death and Disease, Vol. 7, Núm. 10

2015

  1. Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism

    Brain Structure and Function, Vol. 220, Núm. 5, pp. 2721-2738

  2. Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum

    Biochemical Pharmacology, Vol. 96, Núm. 2, pp. 131-142

  3. Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia

    Molecular Neurobiology, Vol. 52, Núm. 3, pp. 1408-1420

2012

  1. Unmasking adenosine 2A receptors (A2ARs) in monkey basal ganglia output neurons using cholera toxin subunit B (CTB)

    Neurobiology of Disease, Vol. 47, Núm. 3, pp. 347-357